New rapid STI test aims to cut treatment wait times
NCT ID NCT07399873
First seen Feb 17, 2026 · Last updated Jun 22, 2026 · Updated 12 times
Summary
This study will test whether a fast, point-of-care test for chlamydia and gonorrhea can reduce the time it takes for people to start antibiotics. Four hundred asymptomatic adults visiting a sexual health clinic will be randomly assigned to receive either the rapid test or a standard lab test. Researchers will measure how quickly treatment begins and how many people complete treatment within a week.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHLAMYDIA TRACHOMATIS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Point-of-care diagnostic test (Cobas Liat CT/NG Assay and CRISPR-based assay)
What this could lead to
If successful, this could make STI testing much faster, allowing people to get treated sooner and reducing the spread of infections.
What could go wrong
This is an early-stage trial focused on speed of treatment, not on curing or preventing disease. The new tests may not be as accurate as standard lab tests, and results may not apply to people with symptoms.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.